SSPL Securities Private Limited

Monday 16 Jun, 2025 09:09 PM

Nucleus Software appoints Aabhinna Khare as CMO to lead global brand transformation Rategain Travel Technologies Ltd leads losers in 'A' group Karma Energy Ltd leads losers in 'B' group Zydus Life subsidiary ZHL appoints Swati Dalal as MD GRM Overseas jumps 26% in eight days Volumes jump at Anand Rathi Wealth Ltd counter Algoquant Fintech incorporates WOS, Algoquant Global Securities Desco Infratech slides after CFO Prinkle Sanjay Jain resigns Punjab & Sind Bank drops for fifth straight session Central Bank of India eases for fifth straight session Indian Overseas Bank drops for fifth straight session UCO Bank drops for fifth straight session Bank of India down for fifth straight session Tips Music Ltd down for fifth straight session Tata Consumer Products Ltd drops for fifth straight session

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Aurobindo Pharma's US arm incorporates Cresedemo Pharma

16-Jun-25 08:40 Hrs IST

The purpose of incorporating this new entity is to expand the company's pharmaceutical products business in USA.

The company has subscribed to a share capital of $10,000 divided into 10,000 shares with a nominal value of $1 each.

Aurobindo Pharma is an integrated global pharmaceutical company headquartered in Hyderabad, India. The company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

The company's consolidated net profit fell 0.6% to Rs 903.47 crore despite a 11.9% jump in net sales to Rs 8,381.12 crore in Q4 FY25 over Q4 FY24.

The scrip declined 0.38% to end at Rs 1,150.65 on the BSE.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 41993095

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)